Euroimmun AG:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Euroimmun AG - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10487
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Euroimmun AG (Euroimmun), a subsidiary of PerkinElmer Inc is a medical device company that provides automation products. The company offers products such as indications, technical IIFT products, and automations. Its indications comprise auto-immune encephalitis, auto antibodies, anti-NMDA receptors, antigen detection systems, E virus identification systems, allergology, and molecular diagnosis products. Euroimmun provides calprotectin ELISA used in the non invasive stool tests. The company offers services such as technical assistance, product management, and IFT image support services. It markets its products through a network of distributors in Brazil, India, Chile, Mexico, the US, Canada, Ecuador, South Africa, Argentina, Peru, the UK, Spain, Egypt, France, Russia, Australia, Latvia, the Czech Republic, and Sri Lanka. Euroimmun is headquartered in Lubeck, Germany.

Euroimmun AG – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Euroimmun AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Euroimmun AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Euroimmun AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Euroimmun AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Euroimmun AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Euroimmun AG, Medical Equipment, Deal Details 10
Partnerships 10
Euroimmun Enters into Licensing Agreement with Iron Horse Diagnostics 10
Euroimmun Enters into Agreement with Angsana Molecular & Diagnostics 11
Acquisition 12
PerkinElmer Acquires Euroimmun for USD1.34 Billion 12
Euroimmun AG – Key Competitors 14
Euroimmun AG – Key Employees 15
Euroimmun AG – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Euroimmun AG, Medical Equipment, Key Facts 2
Euroimmun AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Euroimmun AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Euroimmun AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Euroimmun AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Euroimmun AG, Deals By Market, 2012 to YTD 2018 8
Euroimmun AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Euroimmun Enters into Licensing Agreement with Iron Horse Diagnostics 10
Euroimmun Enters into Agreement with Angsana Molecular & Diagnostics 11
PerkinElmer Acquires Euroimmun for USD1.34 Billion 12
Euroimmun AG, Key Competitors 14
Euroimmun AG, Key Employees 15
Euroimmun AG, Other Locations 16
Euroimmun AG, Subsidiaries 16

List of Figures
Euroimmun AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Euroimmun AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Euroimmun AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Euroimmun AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Euroimmun AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Euroimmun AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Euroimmun AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Euroimmun AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Euroimmun AG:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pandora Media, Inc.:企業のM&A・事業提携・投資動向
    Pandora Media, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pandora Media, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Triskalia:戦略・SWOT・企業財務分析
    Triskalia - Strategy, SWOT and Corporate Finance Report Summary Triskalia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Kansas Electric Power Cooperative, Inc.:企業の戦略的SWOT分析
    Kansas Electric Power Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • GGP Inc:企業の戦略・SWOT・財務情報
    GGP Inc - Strategy, SWOT and Corporate Finance Report Summary GGP Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • AAK AB:企業の戦略・SWOT・財務情報
    AAK AB - Strategy, SWOT and Corporate Finance Report Summary AAK AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • GN Store Nord AS (GN):企業の財務・戦略的SWOT分析
    GN Store Nord AS (GN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Allied Hotel Properties Inc:企業の戦略・SWOT・財務情報
    Allied Hotel Properties Inc - Strategy, SWOT and Corporate Finance Report Summary Allied Hotel Properties Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Consolidated Edison Company of New York, Inc.:発電所・企業SWOT分析
    Consolidated Edison Company of New York, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, in …
  • EnGeneIC Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary EnGeneIC Ltd (EnGeneIC) is a biopharmaceutical company that develops drugs and other therapeutic molecules. The company develops nanocell platform used as a platform for the creation of custom therapies for cancer. Its cyto-immunotherapy platform releases concentrations of RNA-interference m …
  • Haynes International Inc:企業の戦略・SWOT・財務分析
    Haynes International Inc - Strategy, SWOT and Corporate Finance Report Summary Haynes International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Avon Rubber Plc (AVON):企業の財務・戦略的SWOT分析
    Avon Rubber Plc (AVON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • EDF Renewables SA:企業の戦略的SWOT分析
    EDF Renewables SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Kura Oncology Inc (KURA):企業の財務・戦略的SWOT分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate Tipifarnib, an inhibitor of farnesyl transferase, an oral investigational drug candi …
  • Micron Technology Inc:戦略・SWOT・企業財務分析
    Micron Technology Inc - Strategy, SWOT and Corporate Finance Report Summary Micron Technology Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sunwin Stevia International Inc (SUWN):企業の財務・戦略的SWOT分析
    Sunwin Stevia International Inc (SUWN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Eaton Vance Corp.:企業の戦略・SWOT・財務情報
    Eaton Vance Corp. - Strategy, SWOT and Corporate Finance Report Summary Eaton Vance Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Saizeriya Co., Ltd.:企業の戦略・SWOT・財務情報
    Saizeriya Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Saizeriya Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Altimmune Inc-製薬・医療分野:企業M&A・提携分析
    Summary Altimmune Inc (Altimmune), formerly Vaxin Inc is a biotechnology company that develops vaccines and other biological products. The company's products include novel vaccine delivery platforms, immunotherapeutic products, intranasally administered recombinant influenza vaccine, traditional inf …
  • Tri Chemical Laboratories, Inc. (4369):企業の財務・戦略的SWOT分析
    Tri Chemical Laboratories, Inc. (4369) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Terumo Corp (4543):企業の製品パイプライン分析2018
    Summary Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include vascular interventional products, cardiovascular surgical systems, artificial …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆